Notable Labs, Ltd.
NTBLQ
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 313.00K | 311.00K | 310.00K | 130.00K | 8.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 313.00K | 311.00K | 310.00K | 130.00K | 8.00K |
| Cost of Revenue | 197.00K | 197.00K | 197.00K | 31.00K | -- |
| Gross Profit | 116.00K | 114.00K | 113.00K | 99.00K | 8.00K |
| SG&A Expenses | 9.53M | 8.43M | 10.06M | 8.08M | 7.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.68M | 13.29M | 14.97M | 12.94M | 13.27M |
| Operating Income | -15.37M | -12.98M | -14.66M | -12.81M | -13.26M |
| Income Before Tax | -10.54M | -8.76M | -11.26M | -12.54M | -17.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.54 | -8.76 | -11.26 | -12.54 | -17.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.54M | -8.76M | -11.26M | -12.54M | -17.52M |
| EBIT | -15.37M | -12.98M | -14.66M | -12.81M | -13.26M |
| EBITDA | -15.12M | -12.72M | -14.40M | -12.56M | -12.98M |
| EPS Basic | -1.28 | -4.26 | -10.31 | -10.19 | -10.51 |
| Normalized Basic EPS | -0.80 | -2.66 | -6.44 | -6.37 | -6.57 |
| EPS Diluted | -1.28 | -4.26 | -10.31 | -10.19 | -10.51 |
| Normalized Diluted EPS | -0.80 | -2.66 | -6.44 | -6.37 | -6.57 |
| Average Basic Shares Outstanding | 42.92M | 34.44M | 26.39M | 32.79M | 32.79M |
| Average Diluted Shares Outstanding | 42.92M | 34.44M | 26.39M | 32.79M | 32.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |